Axis Small Cap Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies.
Growthvine rating: 3/5 — ranked #11 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹118.11 (as of 2026-08-21) |
|---|
| AUM | ₹30,089 Cr |
|---|
| Expense ratio | 1.35% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Mayank Hyanki |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 15.61% |
|---|
| Sharpe ratio | 0.59 |
|---|
| Standard deviation | 16.77% |
|---|
| Max drawdown | -34.78% |
|---|
| Alpha | 1.87 |
|---|
| Beta | 0.75 |
|---|
Over 5 years, captured 75.3% of NIFTY Smallcap 250's upside and 62.5% of its downside.
Market cap allocation
| Large cap | 7.5% |
|---|
| Mid cap | 11.3% |
|---|
| Small cap | 81.1% |
|---|
Concentration
| Top 5 holdings | 11.3% |
|---|
| Top 10 holdings | 18.5% |
|---|
| Total holdings | 128 |
|---|
| Index overlap | 33.4% |
|---|
| Active share | 66.6% |
|---|
Top holdings
- Clearing Corporation of India Ltd — 4.2%
- Krishna Institute of Medical Sciences Limited — 2.7%
- Torrent Pharmaceuticals Ltd. — 2.6%
- CCL Products (India) Ltd. — 2.6%
- City Union Bank Ltd — 1.8%
- Clearing Corporation of India Ltd — 1.7%
- Sai Life Sciences Limited — 1.6%
- Brigade Enterprises Limited — 1.6%
- Sansera Engineering Limited — 1.5%
- CHOLAMANDALAM FINANCIAL HOLDINGS LIMITED — 1.4%
Top sectors
- Industrial Products — 10.9%
- Banking & Financial — 10.7%
- Chemicals — 7.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 12.7% | Q3 | #19 of 34 |
| 2025 | -2.0% | Q1 (Top) | #8 of 30 |
| 2024 | 25.0% | Q3 | #15 of 28 |
| 2023 | 34.0% | Q4 (Bottom) | #20 of 24 |
| 2022 | 2.6% | Q2 | #9 of 22 |